Literature DB >> 29069582

Assessment of the potential human health risks from exposure to complex substances in accordance with REACH requirements. "White spirit" as a case study.

Richard H McKee1, Rosalie Tibaldi2, Moyinoluwa D Adenuga1, Juan-Carlos Carrillo3, Alison Margary3.   

Abstract

The European chemical control regulation (REACH) requires that data on physical/chemical, toxicological and environmental hazards be compiled. Additionally, REACH requires formal assessments to ensure that substances can be safely used for their intended purposes. For health hazard assessments, reference values (Derived No Effect levels, DNELs) are calculated from toxicology data and compared to estimated exposure levels. If the ratio of the predicted exposure level to the DNEL, i.e. the Risk Characterization Ratio (RCR), is less than 1, the risk is considered controlled; otherwise, additional Risk Management Measures (RMM) must be applied. These requirements pose particular challenges for complex substances. Herein, "white spirit", a complex hydrocarbon solvent, is used as an example to illustrate how these procedures were applied. Hydrocarbon solvents were divided into categories of similar substances. Representative substances were identified for DNEL determinations. Adjustment factors were applied to the no effect levels to calculate the DNELs. Exposure assessments utilized a standardized set of generic exposure scenarios (GES) which incorporated exposure predictions for solvent handling activities. Computer-based tools were developed to automate RCR calculations and identify appropriate RMMs, allowing consistent communications to users via safety data sheets.
Copyright © 2017 ExxonMobil Biomedical Sciences Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Derived No effect level (DNEL); Hazard index; High production volume (HPV); Hydrocarbon solvents; Mineral spirit; REACH regulation; Risk characterization ratio; Risk management measure; UVCB; White spirit

Mesh:

Substances:

Year:  2017        PMID: 29069582     DOI: 10.1016/j.yrtph.2017.10.015

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  2 in total

1.  Grouping of UVCB substances with dose-response transcriptomics data from human cell-based assays.

Authors:  John S House; Fabian A Grimm; William D Klaren; Abigail Dalzell; Srikeerthana Kuchi; Shu-Dong Zhang; Klaus Lenz; Peter J Boogaard; Hans B Ketelslegers; Timothy W Gant; Ivan Rusyn; Fred A Wright
Journal:  ALTEX       Date:  2022-03-10       Impact factor: 6.250

2.  Grouping of UVCB substances with new approach methodologies (NAMs) data.

Authors:  John S House; Fabian A Grimm; William D Klaren; Abigail Dalzell; Srikeerthana Kuchi; Shu-Dong Zhang; Klaus Lenz; Peter J Boogaard; Hans B Ketelslegers; Timothy W Gant; Fred A Wright; Ivan Rusyn
Journal:  ALTEX       Date:  2020-10-09       Impact factor: 6.043

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.